Current Affairs

Anti-Dumping Probe Penicillin G

3.1 Economics, The Hindu, 2026-10-11

India's Directorate General of Trade Remedies (DGTR) initiated an anti-dumping investigation into imports of Penicillin G and its salts from China on a complaint by Lyfius Pharma, an Aurobindo Pharma subsidiary and sole domestic producer. The period of investigation is 2025-26. Lyfius began production under the PLI scheme, reviving output after about three decades. Modi inaugurated its 15,000 tonnes Pen G facility in Kakinada in October 2024, a ₹2,500 crore investment. Pen G is a key starting material and API.